GlassScriptPhysician profile
Howard M Lando
NPI 1699702860
$4,467.03
in general payments reported to CMS, 2019-2025
7 companies · $49.99 in 2025
The $49.99 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,316 · 2020: $84.95 · 2021: $16.36 · 2025: $49.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $49.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $49.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,216.84 | 2019 | |
| Novo Nordisk INC | $78.30 | 2019-2025 | |
| Amgen INC. | $59.24 | 2019-2020 | |
| Horizon Therapeutics Plc | $45.89 | 2019-2020 | |
| Dexcom, INC. | $32.42 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $22.95 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.39 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Lando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.